Manfred Mäder is Head Device Development & Commercialization in TRD (Technical Research and Development). Prior to this, he held the position Head of Global Compliance & Audit for Devices & Combination Products overseeing all Alcon, Pharma, and Sandoz sites producing this type of products and Global QA Head of Technical Research and Development at Novartis Pharma starting in February 2011. Prior to this position he was Senior VP of Quality Management & Regulatory Affairs, at Ypsomed, a company producing Medical Devices and Combination Products starting in 2007. Previously, he was responsible for Quality Assurance Management at Sanofi-Aventis for the Frankfurt Injectables site. Before then, being based in Kansas City/ US, he had a global responsibility for Quality and Regulatory for one of the Aventis Blockbuster products. Prior to that, he held several positions in QA and QC. By training he is pharmacist and holds a doctorate in pharmaceutical analytics and statistics by the University of Wuerzburg/ Germany.
Sessions
A1: Q&A for Integrated Device Development/Holistic Development Strategies
P2: Optimizing Regulatory Outcomes in the Current Environment through Addressing New...
P2: Q&A for Optimizing Regulatory Outcomes in the Current Environment through Addressing New...